首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Urologic oncology-seminars and original investigations

缩写:UROL ONCOL-SEMIN ORI

ISSN:1078-1439

e-ISSN:1873-2496

IF/分区:2.8/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引4576条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Mike Wenzel,Lena Theissen,Carolin Siech et al. Mike Wenzel et al.
Objective: Patient and treatment stratification for metastatic hormone-sensitive prostate cancer (mHSPC) is usually based on metastatic burden according to CHAARTED criteria, classifying high-volume disease as at least 4 ...
Timon Winistoerfer,Simone Scuderi,Giorgio Gandaglia et al. Timon Winistoerfer et al.
Background: Surgical delays increased during the COVID-19 pandemic. The effect of treatment delay in intermediate- and high-risk prostate cancer remains uncertain. We evaluated whether biopsy-to-surgery delay influences e...
Shugo Yajima,Soichiro Yoshida,Naoki Imasato et al. Shugo Yajima et al.
Comparative efficacy among neoadjuvant enfortumab vedotin (EV) monotherapy, EV plus pembrolizumab (EV+P), and immune checkpoint inhibitor (ICI)-based regimens for muscle-invasive bladder cancer (MIBC) is unclear, and we aimed to compare pat...
Daniel J George,Furaha Kariburyo-Yay,Himani Aggarwal et al. Daniel J George et al.
Introduction: The PROfound clinical trial showed that patients with metastatic castration-resistant prostate cancer (mCRPC) who harbored homologous recombination repair gene mutations (HRRm) benefited from receiving olapa...
Daniel L Ranti,Gabriella T Seo,Siddharth Ghanta et al. Daniel L Ranti et al.
Background: Use of renal mass biopsy (RMB) has increased, leading to more diagnoses of renal oncocytoma. Although benign, diagnostic uncertainty and the absence of clear size thresholds for intervention complicate managem...
Wei Zuo,Qi Tang,Xuanjun Guo et al. Wei Zuo et al.
Background and objective: Current surveillance of bladder recurrence for upper tract urothelial carcinoma (UTUC) is limited by invasiveness and sensitivity. There is an urgent need for noninvasive detection tool. We previ...
Luis G Medina,Salvador Jaime-Casas,Federico Eskenazi et al. Luis G Medina et al.
Penile cancer is an uncommon yet aggressive disease, especially at advanced stages. Management can be morbid, and patients often face a significant psychosocial impact alongside a lack of patient advocacy/support system in most parts of the...
Peter S Palencia,Brandon L Ward,Maximilian J Rabil et al. Peter S Palencia et al.
Background: Cystectomy is a potentially morbid procedure that presents a prime opportunity for quality improvement. We hypothesized that a novel electronic medical record (EMR)-based automated algorithm would demonstrate ...
Jacob A Moyer,Mahnoor Ashraf,Lanyu Mi et al. Jacob A Moyer et al.
Background: Sequential intravesical gemcitabine and docetaxel (Gem/Doce) are increasingly used for nonmuscle-invasive bladder cancer (NMIBC), especially in the setting of Bacillus Calmette-Guérin (BCG) shortage or failur...
Ethan Wan,Aditya Sathe,Charles C Peyton et al. Ethan Wan et al.
Introduction: In November 2021, the US FDA approved pembrolizumab in the adjuvant setting for surgically resected clear cell renal cell carcinoma (ccRCC) at high-risk of recurrence, including small pT3a tumors. We hypothe...